PDF) A whole-blood RNA transcript-based gene signature is associated with the development of CTLA-4 blockade-related diarrhea in patients with advanced melanoma treated with the checkpoint inhibitor tremelimumab
Cancers | Free Full-Text | Alterations in HLA Class I-Presented Immunopeptidome and Class I-Interactome upon Osimertinib Resistance in EGFR Mutant Lung Adenocarcinoma
PDF) Variation in the Assessment of Immune-Related Adverse Event Occurrence, Grade, and Timing in Patients Receiving Immune Checkpoint Inhibitors
Isotype -
Pembrolizumab and Decitabine for Refractory or Relapsed Acute Myeloid Leukemia | medRxiv
Northern New England Clinical Oncology Society - 2022 Annual Meeting Accepted Abstracts
Diagnostics | Free Full-Text | Immune-Related Uncommon Adverse Events in Patients with Cancer Treated with Immunotherapy
IJMS | Free Full-Text | Immunobiology of Thymic Epithelial Tumors: Implications for Immunotherapy with Immune Checkpoint Inhibitors
Northern New England Clinical Oncology Society - 2022 Annual Meeting Accepted Abstracts
Cancers | Free Full-Text | Harnessing Tumor Necrosis Factor Alpha to Achieve Effective Cancer Immunotherapy
2021 Southern Medical Research Conference | Journal of Investigative Medicine
Regulatory B cell repertoire defects predispose lung cancer patients to immune-related toxicity following checkpoint blockade | Nature Communications
Northern New England Clinical Oncology Society - 2022 Annual Meeting Accepted Abstracts
Full article: Nivolumab in squamous cell carcinoma of the head and neck
Frontiers | Predictive Biomarkers of Severe Immune-Related Adverse Events With Immune Checkpoint Inhibitors: Prevention, Underlying Causes, Intensity, and Consequences
IJMS | Free Full-Text | Autoimmune Responses in Oncology: Causes and Significance
Server:Area 52 US | WoWWiki | Fandom
Rituximab-Induced Hypogammaglobulinemia and Infections in AQP4 and MOG Antibody- Associated Diseases e977 Potential Role of CHI3
PET Imaging of Lung Cancers in Precision Medicine: Current Landscape and Future Perspective | Molecular Pharmaceutics
Frontiers | Adverse Effects of Anti-PD-1/PD-L1 Therapy in Non-small Cell Lung Cancer
The East Carolinian, March 6, 1997 - ECU Digital Collections
The role of tumor-associated macrophages (TAMs) in tumor progression and relevant advance in targeted therapy - ScienceDirect
Cancers | Free Full-Text | Comedications with Immune Checkpoint Inhibitors: Involvement of the Microbiota, Impact on Efficacy and Practical Implications
Abstracts presented at the 14th European Colorectal Congress (#ECCStGallen), 29.11.2020–2.12.2020, St.Gallen, Switzerland | SpringerLink
The future of cancer treatment: immunomodulation, CARs and combination immunotherapy | Nature Reviews Clinical Oncology
